Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous drug delivery
Pharma
Daiichi enlists Alteogen for subcutaneous Enhertu in $300M deal
Alteogen will use its human hyaluronidase hybridization platform to develop the subcutaneous formulation.
Zoey Becker
Nov 8, 2024 11:19am
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
Sep 13, 2024 1:50pm
Roche's subcutaneous Tecentriq wins FDA nod after delay
Sep 13, 2024 11:41am
Novartis tasks Lindy to turn biologics into at-home injectables
Aug 28, 2024 10:18am
Purdue Pharma snags nod for new overdose-reversal injection
Aug 9, 2024 9:35am
With FDA nod, J&J touts new 'foundational' multiple myeloma combo
Jul 31, 2024 10:39am
